company tower banner
Theravalues Company Logo
THERACURMIN® is a curcumin formulation that improves the problem of low absorption and bioavailability.

Ingredient Name: Turmeric Rhizome Extract

Functions: Phytochemical

Active Component: Curcumene

Physical Form: Capsules, Granules, Solid

    Knowde Enhanced TDS

    Identification & Functionality

    Active Component
    Pharma & Nutraceuticals Functions
    Ingredients
    Curcumin Extract
    Chemical Structure

    THERACURMIN® - Chemical Structure

    Features & Benefits

    Turmeric & Curcumin

    What is turmeric?

    Turmeric is a perennial plant of the ginger family and is widely spread throughout South and Southeast Asian countries. It is commonly used as a spice, flavoring agent, food preservative, and coloring agent, and is known as a key ingredient of curry powder.

    What is curcumin?

    Curcumin is a polyphenol contained in the rhizome of turmeric and is considered to be a main active ingredient of turmeric. It has a bright yellow color and is used as a natural food dye.
    It is also well known for its effect of anti-inflammatory and anti-oxidant amongst medical and health science laboratories all over the world. A great number of researches are being conducted by a variety of medical and science institutes.

    Applications & Uses

    Main evidence for THERACURMIN®
    • Anti-oxidant &
    • Anti-inflammatory Effect
    • Osteoarthritis Effect
    • Muscle fatigue Effect
    • Dementia Effect
    • Liver function Effect
    • Cardiovascular Effect
    • COPD Effect
    • Cancer Treatment
    Line Up

    A highly absorbent curcumin preparation used as a raw material of functional food.
    By crumbling the particles of curcumin and maintaining their particle sizes stably, the particles are absorbed by approximately 27-fold. As it also has water dispersion capability and heat and light resistance characteristics, it is applicable to any forms of products as shown below.

    • Hard capsule
    • Tablet
    • Granules
    • Beverage, Liquid
    • Gummy, chewable, gum
    • Jelly
    • Ice lolly, popsicle, sherbet
    • Noodles

    Properties

    Technical Details & Test Data

    THERACURMIN® Possesses High Bioavailability

    Area Under the Curve(AUC)0-6h values of THERACURMIN® were 27-fold higher than those of curcumin powder.
    AUC0-24 h was found to be 11.0- and 5- fold higher with TEHRACURMIN® than Company A and Company B, respectively.

    Study Protocol

    THERACURMIN® - Theracurmin® Possesses High Bioavailability

    Study design:
    Two arms, randomized parallel-group controlled trial

    Subjects:
    14 healthy subjects (male/female=8/6, age: 44.1±8.5 years old)

    Intake:
    -THERACURMIN®:30mg -Ordinary curcumin: 30mg

    Area Under the Curve(AUC)0-6h values of THERACURMIN® were 27-fold higher than those of curcumin powder.

     

    Study Protocol

    THERACURMIN® - Theracurmin® Possesses High Bioavailability - 1

    Study design:
    Three arms, randomized double-blind 3-way crossover trial

    Subjects:
    9 healthy subjects (male/female=5/4, age: 24-32)

    Intake:
    -THERACURMIN®:180mg
    -Company A: 260mg
    -Company B: 150mg

    AUC0-24 h was found to be 11.0- and 5- fold higher with TEHRACURMIN® than Company A and Company B, respectively.

    Product Highlights

    THERACURMIN® - Product Highlights

    THERACURMIN® - Product Highlights - 1

    Safety and toxicity data of THERACURMIN®
    Toxicity data
    Test Ames test Chromosome aberration test Micronucleus assay test Acute toxicity study
    (Rats)
    Subacute toxicity study
    (Rats)
    Subchronic toxicity study
    (Rats)
    Test detail Salmonella spp.
    (4 strains)
    E.Coli
    In vitro shromosome
    aberration test in
    Chinese hamster lung cells
    Male sprague dewley rats
    bone merrow micronucles assay
    Dose: 1250,2500,5000mg/kg
    (As curcumin 375,750,1500mg/kg)
    Once
    Dose: 0,625,1250,2500,5000mg/kg
    (As curcumin 0,187.5,375,750,1500mg/kg)
    Period: 2 weeks
    Dose: 0,1250,2500,5000mg/kg
    (As curcumin 0,375,750,1500mg/kg)
    Period: 13 weeks
    Result Negative Negative Negative No toxicological findings observed by oral administration No toxicological findings observed by oral administration

    No toxicological findings observed by oral administration

     

    Clinical study in healthy volunteers
    Test 4-week clinical study in healthy volunteers at excessive dosage 12-week clinical study in healthy volunteers at standard dosage
    Test detail Tested dosage: 900mg/q.d./p.o. (as curcumin, 5x of standard dosage)
    Period: 4weeks
    Tested dosage: 180mg/q.d./p.o. (as curcumin standard dosage)
    Period; 12weeks.
    Result THERACURMIN® was proved safe in this study. THERACURMIN® was proved safe in this study.
    • q.d.: Once a day
    • p.o.: Oral intake
    • ADI: Acceptable Daily Intake
    • Standard dosage: 180mg/day (as curcumin)= ADI: 3mg/kg x 60kg (average adult body weight)
    Previous clinical study
    Study title Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial. 12-week clinical study in healthy volunteers at standard dosage
    Test detail Subject: Non-Demented Adults
    THERACURMIN® dose: 180mg/day
    Period: 18 months
    Subject: Patients with stage Ⅰ-ⅡCOPD
    THERACURMIN® dose: 180mg/day
    Period: 6 months
    Result No serious adverse effects were obsevered in this study No serious adverse effects were obsevered in this study